Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Brainsway Ltd.BWAY · Entity 5378 | Chief Scientist | June 01, 2026 | June 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Brainsway Ltd.
Report date June 01, 2026 · Filed June 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 1,072,305 |
Last balance in matching sequence
After 2026-06-02 transaction · row 4
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
4 source rowsRow 1 · 2026-06-01 · Sale · Disposed 2,000 · Balance 1,077,305 F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2: The sale price was NIS 43.64 per share. F3: This figure includes ordinary shares held jointly by Dr. Roth and his spouse and (i) 15,000 ordinary shares and (ii) unvested restricted stock units ("RSUs") to receive 5,000 ordinary shares, with 1,250 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030, each RSU representing a contingent right to receive one ordinary share. Row 2 · 2026-06-01 · Sale · Disposed 2,000 · Balance 1,075,305 F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4: The sale price was NIS 43.45 per share. F3: This figure includes ordinary shares held jointly by Dr. Roth and his spouse and (i) 15,000 ordinary shares and (ii) unvested restricted stock units ("RSUs") to receive 5,000 ordinary shares, with 1,250 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030, each RSU representing a contingent right to receive one ordinary share. Row 3 · 2026-06-02 · Sale · Disposed 1,000 · Balance 1,074,305 F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F5: The sale price was NIS 43 per share. F3: This figure includes ordinary shares held jointly by Dr. Roth and his spouse and (i) 15,000 ordinary shares and (ii) unvested restricted stock units ("RSUs") to receive 5,000 ordinary shares, with 1,250 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030, each RSU representing a contingent right to receive one ordinary share. Row 4 · 2026-06-02 · Sale · Disposed 2,000 · Balance 1,072,305 F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F6: The sale price was NIS 42.0035 per share. F3: This figure includes ordinary shares held jointly by Dr. Roth and his spouse and (i) 15,000 ordinary shares and (ii) unvested restricted stock units ("RSUs") to receive 5,000 ordinary shares, with 1,250 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030, each RSU representing a contingent right to receive one ordinary share. |
Filing footnotes · ownership attribution and instrument terms
F1: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2: The sale price was NIS 43.64 per share.
F3: This figure includes ordinary shares held jointly by Dr. Roth and his spouse and (i) 15,000 ordinary shares and (ii) unvested restricted stock units ("RSUs") to receive 5,000 ordinary shares, with 1,250 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030, each RSU representing a contingent right to receive one ordinary share.
F4: The sale price was NIS 43.45 per share.
F5: The sale price was NIS 43 per share.
F6: The sale price was NIS 42.0035 per share.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 02, 2026 Filed Jun 3, 2026 20:02 UTC | Brainsway Ltd. BWAY · Entity 5378 | SaleOrdinary Shares | 2,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001171843-26-003899 · ownership.xml · nonDerivative · entry 4 Roth Yiftach · CIK 0002111635 · Chief Scientist 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,072,305 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F6 · price: The sale price was NIS 42.0035 per share. F3 · balance_after: This figure includes ordinary shares held jointly by Dr. Roth and his spouse and (i) 15,000 ordinary shares and (ii) unvested restricted stock units ("RSUs") to receive 5,000 ordinary shares, with 1,250 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030, each RSU representing a contingent right to receive one ordinary share. Read SEC document |
| June 02, 2026 Filed Jun 3, 2026 20:02 UTC | Brainsway Ltd. BWAY · Entity 5378 | SaleOrdinary Shares | 1,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001171843-26-003899 · ownership.xml · nonDerivative · entry 3 Roth Yiftach · CIK 0002111635 · Chief Scientist 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,074,305 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F5 · price: The sale price was NIS 43 per share. F3 · balance_after: This figure includes ordinary shares held jointly by Dr. Roth and his spouse and (i) 15,000 ordinary shares and (ii) unvested restricted stock units ("RSUs") to receive 5,000 ordinary shares, with 1,250 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030, each RSU representing a contingent right to receive one ordinary share. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:02 UTC | Brainsway Ltd. BWAY · Entity 5378 | SaleOrdinary Shares | 2,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001171843-26-003899 · ownership.xml · nonDerivative · entry 2 Roth Yiftach · CIK 0002111635 · Chief Scientist 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,075,305 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F4 · price: The sale price was NIS 43.45 per share. F3 · balance_after: This figure includes ordinary shares held jointly by Dr. Roth and his spouse and (i) 15,000 ordinary shares and (ii) unvested restricted stock units ("RSUs") to receive 5,000 ordinary shares, with 1,250 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030, each RSU representing a contingent right to receive one ordinary share. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:02 UTC | Brainsway Ltd. BWAY · Entity 5378 | SaleOrdinary Shares | 2,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001171843-26-003899 · ownership.xml · nonDerivative · entry 1 Roth Yiftach · CIK 0002111635 · Chief Scientist 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,077,305 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · price: The sale price was NIS 43.64 per share. F3 · balance_after: This figure includes ordinary shares held jointly by Dr. Roth and his spouse and (i) 15,000 ordinary shares and (ii) unvested restricted stock units ("RSUs") to receive 5,000 ordinary shares, with 1,250 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030, each RSU representing a contingent right to receive one ordinary share. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.